Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$172,388
-$28,636 QoQ
Shares Held
7,159
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,476
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laraway Financial Advisors Inc holds $5,704,791 across 7 Drug Manufacturers - General names. PFE ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,359 | $2,829,455 | |
| 2 | JNJ |
Johnson & Johnson
|
4,770 | $1,211,436 | |
| 3 | NVS |
Novartis AG
|
2,467 | $386,628 | |
| 4 | NVO |
Novo Nordisk A S
|
7,906 | $379,013 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491 | $375,195 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,729 | $350,676 | |
| 7 | PFE |
Pfizer Inc
This page
|
7,159 | $172,388 |
All Filings in PFE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,388 | 7,159 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $201,024 | 7,159 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $242,999 | 9,759 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $248,659 | 9,759 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $223,226 | 9,209 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $233,356 | 9,209 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $244,314 | 9,209 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $268,042 | 9,262 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $226,721 | 8,103 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $224,858 | 8,103 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $216,011 | 7,503 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $293,654 | 8,853 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $326,562 | 8,903 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $385,274 | 9,443 | Shares | Sole | 2023-06-09 | |
| 2022-12-31 | $512,041 | 9,993 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $462,980 | 10,580 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $545,796 | 10,410 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $563,257 | 10,880 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $650,140 | 11,010 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||